Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Parkinson’s disease

Annovis Bio
Business / Geriatrics

Annovis Bio Reports Positive Results from Final Phase of $1.9M NIH Funded Chronic Toxicology Study

November 13, 2020November 13, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced it successfully completed the …

Read More

Annovis Bio
Products and Services / Research

Annovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial

September 2, 2020September 2, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced dosing of the first …

Read More
Annovis Bio
Geriatrics / Products and Services / Research

Annovis Bio to Present Company’s Novel Approach to Treating Parkinson’s Disease at University of Pennsylvania

July 21, 2020July 21, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, is pleased to announce its …

Read More

Annovis Bio
Products and Services / Research

Annovis Bio Receives Institutional Review Board Approval to Initiate Phase 2 Study

July 8, 2020July 8, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, reported that it has received …

Read More
Annovis Bio
Geriatrics / Products and Services / Research

Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients

May 2, 2020May 2, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced today that the protocol …

Read More

Annovis Bio
Research

Berwyn-based Drug Platform Company Publishes Results of Alzheimer’s and Parkinson’s Animal Studies

April 25, 2020April 25, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, published data from its two double-blind, placebo-controlled …

Read More
Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases
Geriatrics

Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases

February 22, 2020February 22, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company addressing Alzheimer’s, Parkinson’s and other neurodegenerative diseases, was issued a patent (US 10,383,851) in August 2019 for …

Read More

Most Read

  • Federal Housing Administration Announces Extensions of Single Family Policy Flexibilities
  • Outdoor Original Theater Coming to Chester County
  • The Definitive Ranking of Best Cheesesteaks in Chester County
  • FBI Seeks Information on 16 Year Old Cold Case
  • National Consumer Protection Week 2021 Begins Sunday, February 28
  • VA Receives Additional 200,000 COVID-19 Vaccine Doses

Subscribe for Updates

Chester County Events

  • Beer and Bonsai at Victory Taprooms Parkesburg
    • 03/04/2021
      Parkesburg
  • SHI’s 1st Annual Spring Macrobiotic Conference (Online)
    • 03/06/2021
  • SHI’s 1st Annual Spring Macrobiotic Conference (Online)
    • 03/07/2021
  • Real World Self Defense and Law
    • 03/07/2021
      Elverson
  • Coatesville Country Club
    • 03/07/2021
      Coatesville
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • Vishay Intertechnology Launches Industry’s First SMD Ceramic Safety Capacitors With Y1 Rating of 500 VAC and 1500 VDC
  • West Announces Second-Quarter 2021 Dividend
  • PhaseBio Pharmaceuticals to Host Virtual Investor and Analyst Day
  • Secretary of Agriculture Announces Disaster Relief Funding Available for 25 PA Counties
Copyright © 2021 MyChesCo.